EP3430011A4 - A new form of active agent - Google Patents

A new form of active agent Download PDF

Info

Publication number
EP3430011A4
EP3430011A4 EP17868134.2A EP17868134A EP3430011A4 EP 3430011 A4 EP3430011 A4 EP 3430011A4 EP 17868134 A EP17868134 A EP 17868134A EP 3430011 A4 EP3430011 A4 EP 3430011A4
Authority
EP
European Patent Office
Prior art keywords
active agent
new form
new
active
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP17868134.2A
Other languages
German (de)
French (fr)
Other versions
EP3430011A2 (en
Inventor
Mahmut Bilgic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sima Patent Ve Lisanslama Hizmetleri Ltd Sti
Original Assignee
Sima Patent Ve Lisanslama Hizmetleri Ltd Sti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sima Patent Ve Lisanslama Hizmetleri Ltd Sti filed Critical Sima Patent Ve Lisanslama Hizmetleri Ltd Sti
Publication of EP3430011A2 publication Critical patent/EP3430011A2/en
Publication of EP3430011A4 publication Critical patent/EP3430011A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP17868134.2A 2016-11-04 2017-11-03 A new form of active agent Withdrawn EP3430011A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR201615765 2016-11-04
PCT/TR2017/000115 WO2018084817A2 (en) 2016-11-04 2017-11-03 A new form of active agent

Publications (2)

Publication Number Publication Date
EP3430011A2 EP3430011A2 (en) 2019-01-23
EP3430011A4 true EP3430011A4 (en) 2019-08-14

Family

ID=62076190

Family Applications (1)

Application Number Title Priority Date Filing Date
EP17868134.2A Withdrawn EP3430011A4 (en) 2016-11-04 2017-11-03 A new form of active agent

Country Status (2)

Country Link
EP (1) EP3430011A4 (en)
WO (1) WO2018084817A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002030928A1 (en) * 2000-10-12 2002-04-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
WO2012118461A1 (en) * 2011-03-03 2012-09-07 Mahmut Bilgic Crystalline compound comprising tiotropium bromide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR201101897A2 (en) * 2011-02-28 2012-09-21 Bi̇lgi̇ç Mahmut Crystal material containing tiotropium bromide
EP2897955B1 (en) * 2012-09-11 2019-11-06 Bilgic, Mahmut New tiotropium bromide crystalline form

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002030928A1 (en) * 2000-10-12 2002-04-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
WO2012118461A1 (en) * 2011-03-03 2012-09-07 Mahmut Bilgic Crystalline compound comprising tiotropium bromide

Also Published As

Publication number Publication date
EP3430011A2 (en) 2019-01-23
WO2018084817A3 (en) 2018-06-07
WO2018084817A2 (en) 2018-05-11

Similar Documents

Publication Publication Date Title
EP3539150A4 (en) Active showerhead
EP3299936A4 (en) Active stylus
EP3199628A4 (en) Cytotoxicity-inducing therapeutic agent
EP3254721A4 (en) Face mask
EP3192518A4 (en) Anti-inflammatory agent
EP3360426A4 (en) Food-improving agent
EP3245009A4 (en) Antiseptic applicator
EP3229974A4 (en) Antiseptic applicator
GB201621418D0 (en) Cosmetic agent comprising a combination of two mutually different active agents
EP3151835A4 (en) A novel formulation of meloxicam
EP3437595A4 (en) Earmuff
EP3218038A4 (en) Face mask
EP3427743A4 (en) Anti-hepatoma-virus agent
EP3442337A4 (en) Pesticidally active mixtures of tioxazafen
EP3384921A4 (en) New use of thiopeptin
EP3400218A4 (en) Combination of a chromene compound and a second active agent
EP3315131A4 (en) Therapeutic agent for fibrosis
EP3468578A4 (en) Uses of il-41
EP3384767A4 (en) Improved spray
EP3363449A4 (en) Muscle-enhancing agent
EP3153156A4 (en) Composition based on a stabilized solution of active ingredients
EP3721889A4 (en) Use of butyribacter intestini
EP3443965A4 (en) Cognitive function-remedying agent
ZA201606653B (en) Solid forms of a pharmaceutically active compound
EP3377067A4 (en) Skin-penetrating formulation of taurolidine

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20180904

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

A4 Supplementary search report drawn up and despatched

Effective date: 20190716

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/46 20060101ALI20190710BHEP

Ipc: A61P 11/06 20060101ALI20190710BHEP

Ipc: C07D 451/10 20060101AFI20190710BHEP

Ipc: A61K 45/06 20060101ALI20190710BHEP

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20200213